Our Pedro Ramirez, M.D., caused a stir at the Society of Gynecologic Oncology’s annual meeting in March when he reported unexpected findings in his Phase III study comparing minimally invasive surgery to open surgery for early-stage cervical cancer.

The trial had stopped signing up new patients early, because patients who underwent minimally invasive laparoscopic or robotic surgery for hysterectomy — rather than having open surgery...